[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2062887T3 - Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno. - Google Patents

Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno.

Info

Publication number
ES2062887T3
ES2062887T3 ES92903034T ES92903034T ES2062887T3 ES 2062887 T3 ES2062887 T3 ES 2062887T3 ES 92903034 T ES92903034 T ES 92903034T ES 92903034 T ES92903034 T ES 92903034T ES 2062887 T3 ES2062887 T3 ES 2062887T3
Authority
ES
Spain
Prior art keywords
hpv39
genome
papilomavirus
application
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92903034T
Other languages
English (en)
Inventor
Gerard Orth
Christoph Volpers
Rolf E Streeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of ES2062887T3 publication Critical patent/ES2062887T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION SE REFIERE A UNA SECUENCIA DE ADN QUE CORRESPONDE AL GENOMA ENTERO O PARCIAL DE HPV39. APLICACION IN VITRO DE UNA INFECCION DEBIDA A HPV39 O A VARIANTES DE ESTE EN UNA MUESTRA BIOLOGICA.
ES92903034T 1990-12-20 1991-12-20 Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno. Expired - Lifetime ES2062887T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9016044A FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.

Publications (1)

Publication Number Publication Date
ES2062887T3 true ES2062887T3 (es) 1994-12-16

Family

ID=9403488

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92903034T Expired - Lifetime ES2062887T3 (es) 1990-12-20 1991-12-20 Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno.

Country Status (10)

Country Link
US (2) US5656423A (es)
EP (1) EP0563255B1 (es)
JP (1) JP3859696B2 (es)
AT (1) ATE112316T1 (es)
CA (2) CA2375673C (es)
DE (1) DE69104380T2 (es)
DK (1) DK0563255T3 (es)
ES (1) ES2062887T3 (es)
FR (1) FR2670797A1 (es)
WO (1) WO1992011369A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
ATE370251T1 (de) * 1998-10-26 2007-09-15 Ventana Med Syst Inc Nachweis des humanen papilloma-virus mit hilfe des papanicolau-tests
US7569344B2 (en) * 1998-10-26 2009-08-04 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (Pap) smears
AU778737B2 (en) * 1999-04-14 2004-12-16 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
US7312041B2 (en) * 2001-02-16 2007-12-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
US20040229298A1 (en) * 2000-11-11 2004-11-18 Lu Peter S. Methods and compositions for treating cervical cancer
US7410758B2 (en) * 2001-07-20 2008-08-12 Board Of Regents, The University Of Texas System Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
US7704965B2 (en) * 2002-06-26 2010-04-27 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
JP4694840B2 (ja) 2002-09-09 2011-06-08 アルボー ビータ コーポレーション 子宮頸部癌を検査する方法
CA2539703C (en) 2003-09-25 2011-06-07 Third Wave Technologies, Inc. Detection of human papilloma virus (hpv) utilizing invasive cleavage structure assays
JP5030594B2 (ja) 2003-12-23 2012-09-19 アルボー ビータ コーポレーション Hpvの発癌性株に対する抗体およびそれらの使用方法
CA2588581C (en) 2004-12-08 2011-05-31 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
CA2589912C (en) * 2004-12-10 2019-03-05 Genera Biosystems Pty Ltd A beadset and method for detecting human papilloma virus (hpv)
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US8865162B2 (en) 2008-06-13 2014-10-21 Oncohealth Corp. Monoclonal antibodies against HPV proteins
BRPI0809958C1 (pt) * 2007-04-05 2021-07-27 Genera Biosystems Ltd conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico
GB0820822D0 (en) * 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
JP2012526286A (ja) 2009-05-07 2012-10-25 オンコヘルス コーポレーション ヒトパピローマウイルス(hpv)およびhpv関連癌の初期段階および後期段階の検出、スクリーニング、および診断のための高度または≧cin2の同定
US9128094B2 (en) 2010-01-08 2015-09-08 Oncohealth Corp. High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers
AU2011258501B2 (en) * 2010-05-25 2016-07-07 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593828B2 (fr) * 1986-01-31 1990-05-04 Pasteur Institut Sonde a papillomavirus et procede de diagnostic in-vitro d'infections a papillomavirus
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
FR2641081A1 (es) * 1988-12-23 1990-06-29 Medgenix Group

Also Published As

Publication number Publication date
US5665535A (en) 1997-09-09
WO1992011369A1 (fr) 1992-07-09
DE69104380T2 (de) 1995-02-09
US5656423A (en) 1997-08-12
CA2375673A1 (fr) 1992-07-09
DK0563255T3 (da) 1994-10-24
DE69104380D1 (de) 1994-11-03
JPH06504672A (ja) 1994-06-02
FR2670797A1 (fr) 1992-06-26
JP3859696B2 (ja) 2006-12-20
EP0563255B1 (fr) 1994-09-28
EP0563255A1 (en) 1993-10-06
CA2375673C (fr) 2005-05-17
FR2670797B1 (es) 1994-08-19
CA2098819C (fr) 2002-06-18
CA2098819A1 (fr) 1992-06-21
ATE112316T1 (de) 1994-10-15

Similar Documents

Publication Publication Date Title
ES2062887T3 (es) Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno.
DK605987D0 (da) Bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater
DE60139026D1 (de) Lebender influenza impfstoff und verfahren zu seiner herstellung
HUP0202639A2 (en) Immunostimulatory nucleic acids
MY104590A (en) Improvements in or relating to organic compounds.
ES2129386T1 (es) Vacuna contra influenza.
EP1715064A8 (fr) Séquences nucléotidiques issues du génome des rétrovirus du type HIV-1, HIV-2 et SIV, et leurs applications notamment pour l'amplification des génomes de ces rétrovirus et pour le diagnostic in vitro des infections dûes à ces virus
YU37502A (sh) Infektivni klonovi
CA2055612A1 (fr) Sequences oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in-vitro des infections dues a ces virus
ES2076143T3 (es) Plantas resistentes a virus que tienen arn antisentido.
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
DK1334119T3 (da) Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet
DE69627526D1 (de) Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
ES468363A1 (es) Proceso para la fabricacion de un preparado destinado al tra-tamiento de herpes-zoster.
AU5460900A (en) Infectious cdna clone of gb virus b and uses thereof
ES2054230T3 (es) Un proceso para la preparacion de un enterovirus o rinovirus atenuado.
EE200200157A (et) Vaktsiin
FR2600079B1 (fr) Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus
ES2068811T5 (es) Plantas resistentes a virus que tienen una proteina de cubierta viral.
ATE107361T1 (de) Gen des hüllproteins des gurkenmosaikvirus.
ES2169040T3 (es) Planta resistente a dos o mas virus y preparacion de la misma.
MXPA03000278A (es) Uso de cepas de parapoxvirus ovis frente a fibrosis de organos.
DK0540525T3 (da) Fremgangsmåde til fremstilling af vacciner og anvendelse af de således fremstillede vacciner
AR021143A1 (es) Identificacion de genotipos senv
ATE499383T1 (de) Eine methode zur herstellung von menschlichem natürlichem interferon-alpha

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 563255

Country of ref document: ES